Compare SLRC & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLRC | CERT |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 803.0M | 860.9M |
| IPO Year | 2007 | 2020 |
| Metric | SLRC | CERT |
|---|---|---|
| Price | $16.16 | $6.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $15.14 | $11.67 |
| AVG Volume (30 Days) | 280.6K | ★ 4.3M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | ★ 10.26% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 1.70 | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $1.48 | $4.18 |
| Revenue Next Year | N/A | $5.39 |
| P/E Ratio | $9.40 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $13.78 | $5.19 |
| 52 Week High | $17.20 | $15.38 |
| Indicator | SLRC | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 72.69 | 53.72 |
| Support Level | $14.88 | $6.04 |
| Resistance Level | $16.67 | $7.52 |
| Average True Range (ATR) | 0.37 | 0.30 |
| MACD | 0.20 | 0.13 |
| Stochastic Oscillator | 90.76 | 88.84 |
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.